Self-Testing Market Size, Share & Trends Analysis Report By Product Type (Kits, Device, Strips), By Applications, By Sample Type, By End-users, By Usage, By Region, And Segment Forecasts, 2023 To 2030

Self-test/kits are utilized for the rapid diagnostics in various disorders. Recently, there are various types of self-testing kits are available in the market. These kits are simple and quick tests for ovulation. In addition, individuals can also monitor blood pressure as well as test for hepatitis C, colon cancer, urinary tract infections, HIV, and deteriorating vision. Some self-tests offers results right away, whereas others are sample collection devices that require to be mailed to a lab for processing. People are moving toward the self-tests/kits as it’s convenient and gives quick result.Development of highly affordable and easily available kits that can be used within home healthcare settings further reduce the additional costs associated with complex diagnostic procedures, thereby positively influencing the use of self-test POC testing kits.

Telemedicine continues to emerge to the extent of different groups of individuals globally. The COVID-19 pandemic has a ramp up the growth of medicines in several new parts of the globe. Several organizations undertook various initiatives to prevent severe illness, hospitalization or death. For instance, in January 2023, the NIH and Administration for Strategic Preparedness and Response (ASPR) entered into a collaboration to introduce the Home Test to Treat program, a virtual community health intervention that would deliver free COVID health services- telehealth sessions, home treatments and at-home rapid tests-in selected communities.

Funding from sources such as public & private sectors and philanthropic organizations for development of novel and robust diagnostics has created lucrative opportunities for diagnostics developers to establish their presence in the self-testing/kits market.The public sector has been the key source of funding in the diagnostic sector over the past years and accounted for the major share of the total funding. For instance, in January 2022, Florida Atlantic University (FAU) approved around USD 1.3 million to NIH for develop automated, rapid HIV self-kits. Under this initiative, another USD 1.3 million would be approved after a programmatic review of the progress complete in first phase.

Several initiatives by key entities and ongoing technological development are expected to create growth opportunities for the Self-testing/kits market. For instance, in November 2022, F. Hoffmann-La Roche launched Pilot COVID-19 At-Home Test, a new name and brand for the COVID-19 Test, to expand retail channels for COVID-19 At-Home Test. This test shows relative specificity of 100% and relative sensitivity of 93.2%. Moreover, in May 2022,Laboratory Corporation of America Holdings introduced a novel At-home Collection Kit over LabCorp OnDemand for Diabetes Risk Testing. This test can measure haemoglobin A1c (HbA1c) from a small sample of blood. The Labcorp OnDemand Diabetes Risk kit applies dried blood tools to deliver a snapshot of the body’s normal sugar levels.

Self-testing/kits Market Segmentation

Major players operating in the Self-testing market include Johnson & Johnson, Geratherm Medical AG, B. Braun Holding GmbH, Piramal Enterprises, Cardinal Health,OraSure Technologies, Inc., bioLytical Laboratories Inc., PRIMA Lab SA., Becton, Dickinson & Company,Roche Holding AG, Bionime Corporation and others.